K222884 is an FDA 510(k) clearance for the Rapid NCCT Stroke. Classified as Radiological Computer-assisted Triage And Notification Software (product code QAS), Class II - Special Controls.
Submitted by Ischemaview, Inc. (Golden, US). The FDA issued a Cleared decision on March 2, 2023 after a review of 161 days - an extended review cycle.
This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2080 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.
View all Ischemaview, Inc. devices